DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

100 Episodo

1. Introducing DrugChatter: Revolutionizing Information Access

   Publicado: 25/6/2024
2. USPTO Study Reveals Trends and Insights into Drug Patent and Exclusivity Trends in the Pharmaceutical Industry

   Publicado: 25/6/2024
3. Leveraging 505(b)(2) to Innovate Beyond Existing Drug Patents

   Publicado: 24/6/2024
4. The Intricate Journey of Drug Patents: From Filing to Expiry

   Publicado: 20/6/2024
5. Uncovering Lucrative Low-Competition Generic Drug Opportunities

   Publicado: 19/6/2024
6. Maximizing ROI with Branded Generics: A Comprehensive Guide

   Publicado: 18/6/2024
7. A Practical Guide to FtO Analysis for Drug Repurposing Ventures

   Publicado: 17/6/2024
8. Divisional Patent Minefields: Navigating Big Pharma’s Patent Extension Strategies

   Publicado: 17/6/2024
9. Innovative Approaches to Extend the Life of Drug Patents

   Publicado: 17/6/2024
10. How long does a patent last for drugs?

    Publicado: 12/6/2024
11. Crucial Insights on Patent Litigation Strategies in Pharma Industry

    Publicado: 10/6/2024
12. Underutilized Opportunities: Exploring Patent Term Extensions for Medical Devices

    Publicado: 6/6/2024
13. Innovative Strategies in Drug Repurposing

    Publicado: 23/4/2024
14. AI-Driven Drug Discovery: Transforming the Landscape of Pharmaceutical Research

    Publicado: 16/4/2024
15. Innovative Financing Models for Repurposing Generic Drugs

    Publicado: 11/4/2024
16. Biosimilar Competition Does Not Reduce Patient Out-of-Pocket Costs for Biologic Drugs

    Publicado: 31/3/2024
17. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Publicado: 22/3/2024
18. LACTOSE-Free Medicines: Which Drugs Contain LACTOSE?

    Publicado: 8/3/2024
19. GELATIN-Free Medicines: Which Drugs Contain GELATIN?

    Publicado: 6/3/2024
20. Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma

    Publicado: 26/2/2024